Cargando…
Dichloroacetate (DCA) and Cancer: An Overview towards Clinical Applications
An extensive body of literature describes anticancer property of dichloroacetate (DCA), but its effective clinical administration in cancer therapy is still limited to clinical trials. The occurrence of side effects such as neurotoxicity as well as the suspicion of DCA carcinogenicity still restrict...
Autores principales: | Tataranni, Tiziana, Piccoli, Claudia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6885244/ https://www.ncbi.nlm.nih.gov/pubmed/31827705 http://dx.doi.org/10.1155/2019/8201079 |
Ejemplares similares
-
Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer
por: Michelakis, E D, et al.
Publicado: (2008) -
Honokiol bis-dichloroacetate (Honokiol DCA) demonstrates activity in vemurafenib-resistant melanoma in vivo
por: Bonner, Michael Y., et al.
Publicado: (2016) -
Dichloroacetate Affects Mitochondrial Function and Stemness-Associated Properties in Pancreatic Cancer Cell Lines
por: Tataranni, Tiziana, et al.
Publicado: (2019) -
Mito-DCA: A Mitochondria Targeted Molecular Scaffold
for Efficacious Delivery of Metabolic Modulator Dichloroacetate
por: Pathak, Rakesh K., et al.
Publicado: (2014) -
Dichloroacetate, a selective mitochondria-targeting drug for oral squamous cell carcinoma: a metabolic perspective of treatment
por: Ruggieri, Vitalba, et al.
Publicado: (2014)